Biological functions
| Function Type | Function ID | Description | GeneRatio | BgRatio | pvalue | padjust | qvalue | GeneCount | RABCID | |
|---|---|---|---|---|---|---|---|---|---|---|
| KEGG | hsa04666 | Fc gamma R-mediated phagocytosis | 36/1523 | 97/8135 | 0.0000146 | 0.001629 | 0.001335 | 36 | RABC89 | |
| KEGG | hsa04514 | Cell adhesion molecules | 48/1523 | 149/8135 | 0.000049 | 0.00336 | 0.002753 | 48 | RABC89 | |
| KEGG | hsa00100 | Steroid biosynthesis | 12/1523 | 20/8135 | 0.0000503 | 0.00336 | 0.002753 | 12 | RABC89 | |
| KEGG | hsa04071 | Sphingolipid signaling pathway | 40/1523 | 119/8135 | 0.0000716 | 0.00359 | 0.002941 | 40 | RABC89 | |
| KEGG | hsa04510 | Focal adhesion | 60/1523 | 201/8135 | 0.0000752 | 0.00359 | 0.002941 | 60 | RABC89 | |
| KEGG | hsa04530 | Tight junction | 52/1523 | 169/8135 | 0.0000948 | 0.003956 | 0.003241 | 52 | RABC89 | |
| KEGG | hsa04611 | Platelet activation | 40/1523 | 124/8135 | 0.0001968 | 0.006715 | 0.005502 | 40 | RABC89 | |
| KEGG | hsa04360 | Axon guidance | 54/1523 | 182/8135 | 0.000201 | 0.006715 | 0.005502 | 54 | RABC89 | |
| KEGG | hsa04915 | Estrogen signaling pathway | 43/1523 | 138/8135 | 0.0002736 | 0.008308 | 0.006808 | 43 | RABC89 | |
| KEGG | hsa00280 | Valine, leucine and isoleucine degradation | 19/1523 | 48/8135 | 0.0005997 | 0.01669 | 0.01368 | 19 | RABC89 | |
| KEGG | hsa04062 | Chemokine signaling pathway | 54/1523 | 192/8135 | 0.0008471 | 0.02158 | 0.01769 | 54 | RABC89 | |
| KEGG | hsa04015 | Rap1 signaling pathway | 58/1523 | 210/8135 | 0.0009047 | 0.02158 | 0.01769 | 58 | RABC89 | |
| KEGG | hsa05202 | Transcriptional misregulation in cancer | 39/772 | 193/8135 | 0.00000367 | 0.001189 | 0.001074 | 39 | RABC14 | |
| KEGG | hsa04640 | Hematopoietic cell lineage | 23/772 | 99/8135 | 0.0000382 | 0.006184 | 0.005585 | 23 | RABC14 | |
| KEGG | hsa05215 | Prostate cancer | 20/772 | 97/8135 | 0.0006498 | 0.07018 | 0.06339 | 20 | RABC14 | |
| KEGG | hsa04152 | AMPK signaling pathway | 120/6848 | 120/8135 | 0.000000000896 | 0.000000229 | 0.000000098 | 120 | RABC28 | |
| KEGG | hsa05205 | Proteoglycans in cancer | 199/6848 | 205/8135 | 0.00000000167 | 0.000000229 | 0.000000098 | 199 | RABC28 | |
| KEGG | hsa04261 | Adrenergic signaling in cardiomyocytes | 148/6848 | 150/8135 | 0.00000000205 | 0.000000229 | 0.000000098 | 148 | RABC28 | |
| KEGG | hsa05165 | Human papillomavirus infection | 312/6848 | 331/8135 | 0.00000000879 | 0.000000617 | 0.000000264 | 312 | RABC28 | |
| KEGG | hsa04934 | Cushing syndrome | 152/6848 | 155/8135 | 0.00000000924 | 0.000000617 | 0.000000264 | 152 | RABC28 | |
| KEGG | hsa04022 | cGMP-PKG signaling pathway | 163/6848 | 167/8135 | 0.0000000114 | 0.000000634 | 0.000000272 | 163 | RABC28 | |
| KEGG | hsa04510 | Focal adhesion | 194/6848 | 201/8135 | 0.0000000167 | 0.000000705 | 0.000000302 | 194 | RABC28 | |
| KEGG | hsa04919 | Thyroid hormone signaling pathway | 120/6848 | 121/8135 | 0.0000000182 | 0.000000705 | 0.000000302 | 120 | RABC28 | |
| KEGG | hsa04080 | Neuroactive ligand-receptor interaction | 331/6848 | 353/8135 | 0.000000019 | 0.000000705 | 0.000000302 | 331 | RABC28 | |
| KEGG | hsa04935 | Growth hormone synthesis, secretion and action | 118/6848 | 119/8135 | 0.0000000254 | 0.000000847 | 0.000000363 | 118 | RABC28 | |
| KEGG | hsa04810 | Regulation of actin cytoskeleton | 209/6848 | 218/8135 | 0.0000000354 | 0.00000108 | 0.000000461 | 209 | RABC28 | |
| KEGG | hsa04360 | Axon guidance | 176/6848 | 182/8135 | 0.0000000474 | 0.00000132 | 0.000000565 | 176 | RABC28 | |
| KEGG | hsa04024 | cAMP signaling pathway | 211/6848 | 221/8135 | 0.0000000995 | 0.00000256 | 0.0000011 | 211 | RABC28 | |
| KEGG | hsa04020 | Calcium signaling pathway | 228/6848 | 240/8135 | 0.000000125 | 0.00000297 | 0.00000128 | 228 | RABC28 | |
| KEGG | hsa04910 | Insulin signaling pathway | 134/6848 | 137/8135 | 0.000000151 | 0.00000337 | 0.00000144 | 134 | RABC28 |